Chronic Obstructive Pulmonary Disease Exhibits Emerging Pipeline with 60+ Drug Candidates

The study analyzed that the chronic obstructive pulmonary disease pipeline comprises 65 drug candidates in different stages of development. Chronic obstructive pulmonary disease is a broad term used for progression of various other diseases that affect the lungs such as, emphysema, chronic bronchitis.

As per the findings of the research, most of the drug candidates of chronic obstructive pulmonary disease pipeline are being developed to be administered by inhalation route.

MorphoSys AG is using human combinatorial antibody library (HuCAL) technology platform for the development of their drug candidates in chronic obstructive pulmonary disease. The technology is used for the in vitro generation of highly specific and fully human antibodies.

The research found that various companies have collaborated for the development of chronic obstructive pulmonary disease therapeutics pipeline. In March 2017, Kyowa Hakko Kirin Co., Ltd. collaborated with AstraZeneca plc, had given the exclusive rights to AstraZeneca plc for benralizumab in Asia.

Some of the key players developing drugs for the treatment of chronic obstructive pulmonary disease include AstraZeneca plc, GlaxoSmithKline plc, Adamis Pharmaceuticals Corporation and others.

News Courtesy : P&S Market Research

Lysosomal Storage Disorder Therapeutics Exhibits Emerging Pipeline with 70+ Drug Candidates

Lysosomal Storage Disorder Therapeutics Pipeline

The study analyzed that the lysosomal storage disorder therapeutics pipeline comprises approximately 74 drug candidates in different stages of development.

According to the research findings, most of the drug candidates for lysosomal storage disorder pipeline are being developed to be administered by intravenous route.

Amicus Therapeutics, Inc. is using chaperone advanced replacement therapy (CHART) technology platform for the development of their drug candidates for the treatment of Fabry disease, a type of lysosomal storage disorder. In a chaperone-advanced replacement therapy, a unique pharmacological chaperone, binds to the infused therapeutic enzyme, stabilizing the enzyme in its properly folded and active form. This proposed CHART mechanism may allow for enhanced tissue uptake, greater lysosomal activity, more reduction of storage material, and lower immunogenicity compared to ERT alone.

The research also found that various companies use natural sources for the development of lysosomal storage disorder therapeutics pipeline. Protalix BioTherapeutics, Inc. is developing their drug candidates, obtained from a natural source, for the treatment of Fabry disease.

Some of the other key players developing drugs for the treatment of lysosome storage disorder include GlaxoSmithKline plc, Sanofi Genzyme, Amicus Therapeutics, Inc. and others.

News Courtesy : P&S Market Research

Magnetic Resonance Imaging Advanced Visualization Contributes Largest Revenue to the Global Advanced Visualization Market

Advanced Visualization Market

According to the study, the global advanced visualization market is likely to grow from $1.8 billion in 2016 to $3.8 billion by 2023. Technological advancements, increasing demand for efficient and early diagnosis of diseases, and increasing prevalence of chronic diseases have been driving the growth of the global advanced visualization market. The market is further expected to gain revenue due to increasing geriatric population and incorporation of advanced visualization solutions in mobile devices. Integration of picture archiving and communication system (PACS) and advanced visualization solutions along with the rising demand from developing nations would create ample opportunities for the global advanced visualization vendors.

As per the findings of research, hardware and software held larger share in the global market in 2016, primarily due to increasing installation of advanced visualization hardware and software in healthcare settings. The advanced visualization service market is expected to witness higher growth during the forecast period. The higher growth for services is attributed to the increasing demand for the implementation of advanced visualization solutions and training and education services. Among different type of advanced visualization solutions, enterprise-wide thin client-based solutions held larger share in the global market in 2016, and it is also expected to witness higher growth during the forecast period. Improved data storage capacity, multi-user interface, centralized post-processing solutions, streamlined analysis, and enhanced data transfer capabilities of these solutions is significantly driving the growth of the global enterprise-wide thin client-based solutions market.

Geographically, North America has been the largest market for advanced visualization, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American advanced visualization market are technological advancements, increasing healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of chronic diseases. According to the World Health Organization, approximately 324,000 new cases of lung cancer were diagnosed in North America in 2012, and the number is estimated to reach approximately 541,000 by 2030. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by 2023.

Key companies in the advanced visualization market are collaborating to offer better advanced visualization solutions. In November 2016, TeraRecon, released an advanced integration between iNtuition with Agfa HealthCare’s Enterprise Imaging 8.1. The combined solution provides single user interface for accessing 2D and advanced 3D applications, bi-directional communication between Agfa and TeraRecon viewers, and multi-series data loading for 3D analysis.

Some of the other key players in the market include General Electric Company, Canon, Inc., Siemens AG, Koninklijke Philips N.V, Fujifilm Holdings Corporation, Carestream Health, Agfa-Gevaert N.V., and Ziosoft.

News Courtesy : P&S Market Research

CT Contributes Largest Revenue to the Global Vascular Imaging Systems Market

Vascular Imaging System Market

According to the study, the global vascular imaging systems market is likely to grow significantly, during the forecast period, due to increasing healthcare expenditure, increasing prevalence of cancer and cardiovascular diseases and rising awareness about imaging techniques due to various conferences and seminars. In addition, growing geriatric population and launch of technologically advanced products contribute to the growth of the market. High cost, stringent regulatory requirements, shortage of helium for magnetic resonance imaging and increasing risk of cancer due to exposure to radiations are the key factors restraining the global market growth.

Geographically, North America has been the largest market for vascular imaging systems, where the U.S. has been the largest contributor to the regional market. Increasing awareness about imaging techniques has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the market, followed by the U.K. and France. Asia-Pacific market is expected to grow at the highest CAGR, during 2017 – 2023, owing to increasing prevalence of cancer and cardiovascular diseases.

According to the Conference of Radiation Control Program Directors, Inc. (CRCPD), around 62 million CT procedures are performed every year in the U.S. including 4 million CT procedures performed for children. Moreover, according to the European Association of Nuclear Medicine (EANM) annual congress, the number of patients in Western Europe undergoing PET procedures increased by 21% between 2005 and 2010, accounting for 900,000 procedures in 2011. The rapidly increasing demand for vascular imaging procedures drives the growth of the market.

Some of the key players in the global market include Siemens AG, General Electric Company, Hitachi Ltd., and Koninklijke Philips N.V., Carestream Health, Inc., Hologic, Inc., Esaote S.P.A, Shimazdu Corporation, Canon Inc., Orthoscan, Inc., and Fujifilm Corporation.

News Courtesy : P&S Market Research

Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global Active Implantable Medical Devices Market

Active Implantable Medical Devices Market

The global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.

Geographically, North America has been the largest market for active implantable medical devices, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American active implantable medical devices market are technological advancements, high healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of cardiovascular diseases. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by 2023. Asia-Pacific presents several growth opportunities for the active implantable medical devices manufacturers due to the rapid expansion of healthcare industry in the region.

Key companies in the active implantable medical devices market are acquiring other companies to strengthen their position in the global market. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., including its atrial fibrillation, structural heart and heart failure business as well as neuromodulation business. Similarly, in January 2015, Medtronic plc completed the acquisition of Covidien plc. Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. The acquisition strengthened position of the company in the global market with a large number of product offerings.

Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.

News Courtesy : P&S Market Research

Global Adhesion Barrier Market is Driven by Increased Sports Related Injury Cases

Adhesion Barrier Market Size

The global adhesion barrier market was valued at $761.0 million in 2015 and it is expected to grow at a CAGR of 8.5% during the period 2016 – 2022. The adhesion barrier market is growing due to increasing geriatric population, increase in volume of surgeries and increasing sports related injuries.

Among the type of product, synthetic adhesion barrier product accounted for the largest share in the global market in 2015, and it is expected to witness 8.6% CAGR during 2016 – 2022. Among the various applications, gynecological surgeries segment is expected to witness the fastest growth during the forecast period.

Geographically, North America has been globally the largest market of adhesion barriers, owing to the growing cases of abdominal problems, neurological diseases and cardiovascular diseases in the region. However, the adhesion barrier market is expected to witness fastest growth in Asia-Pacific, with a CAGR of 8.8% during the period 2016– 2022. The high growth is attributed to increasing awareness about adhesion barriers, improvements in healthcare infrastructure, and rising disposable income in the region.

Some of the key companies operating in the global adhesion barrier market include Medtronic plc, Baxter International Inc., Johnson & Johnson, Sanofi Group, C. R. Bard Inc., MAST Biosurgery AG, Getinge AB, Anika Therapeutics Inc., FzioMed, Inc. and Integra LifeSciences Corporation.

News Courtesy : P&S Market Research

Global Marketing Automation Software Market to Witness 8.5% CAGR During 2017 – 2023

The study reveals that the global marketing automation software market is likely to grow from $3,943.2 million in 2016 to $6,929.7 million by 2023, on account of growing demand for greater digital customer experience, and automated customer retention.

Insights on market segments

As per findings of the research, e-mail marketing segment has been the leading contributor to the global marketing automation software market; however, demand for marketing automation software from technology industry is expected to grow at the fastest pace during the forecast period.

North America stands as the largest marketing automation software market

Geographically, North America has been the largest market for marketing automation software, across the globe, while Asia-Pacific is expected to grow at the fastest rate during the forecast period.

Growing need for personalized mails and enhanced digital customer experience to elevate Global Marketing Automation Software Market growth

Factors driving the global marketing automation software market include growing demand for digital experience for customers, adoption of customer scoring system, and increased need of personalized automated e-mails.

Globally, with rapidly increasing digital environment, personal attention towards customers matters the most to the businesses. Marketing automation helps in reaching out to the customers, digitally, by monitoring user’s choice of products through the data collected from the automation software. It further helps in predicting the potential customers for additional sales. Some of the major trends observed in the global marketing automation software market are dynamic campaign management and integrated content marketing.

Moderate competition among players in the global marketing automation software market

The research states that the global marketing automation software market is competitive with many players introducing their product offerings. Some of the key players operating in the global marketing automation software market are Marketo Inc., Act-On Software Inc., HubSpot Inc., Infusion Software Inc., Oracle Corporation, IBM Corporation, Salesforce.com Inc, Active Campaign Inc., SharpSpring Inc., and Adobe systems Inc.

News Courtesy : P&S Market Research

Global Smart Homes Market to Reach $70,208.6 Million by 2023

Due to increasing internet penetration globally, and significant growth in automation technologies such as internet of things (IoT), the global smart homes market is gaining huge traction. Furthermore, recent developments in home automation technologies have resulted in drop in prices of sensors and processors, which are contributing to the growth of global smart homes market. Technology manufacturers investing and promoting automation in residential and household sector are also expected to back the global market growth.

As per the findings of the research, home entertainment system segment has been the largest revenue generator among the various product segments in the global smart homes market. Smart home healthcare segment is expected to witness the fastest growth during the forecast period.

Geographically, North America has been the largest market for smart homes; whereas, the market is expected to witness the fastest growth in Asia-Pacific, during the forecast period. The anticipated high growth in Asia-Pacific can be attributed to factors such as advancement in home automation technologies, rapid growth in industry digitalization, new technological developments in telecom industry, along with setting up of advanced hardware and software manufacturing units, and increasing adoption of data analytics across industries in the region.

The research states that the global smart homes market is moderately competitive, with players investing in advanced research & development of new home automation solutions. Some of the key players operating in the global smart homes market are Honeywell International Inc., Siemens AG, Schneider Electric SE, ABB Limited, Johnson Controls Inc., Samsung Electronics Co. Ltd., United Technology Corporation, and Cisco Systems Inc.

News Courtesy : P&S Market Research

Global Commercial Satellite Imaging Market to Witness 11.2% CAGR during 2017 – 2023

As per the research, the global commercial satellite imaging market is likely to witness double digit growth during the forecast period. The commercial satellite imaging market offers geospatial data and information in the form of real-time images. These images captured through satellite imagery systems are utilized for several purposes, including natural resource management, surveillance of terror prone border areas, mapping of vast constructional projects and for environment monitoring and management.

Geospatial data acquisition & mapping has been the largest application segment in the commercial satellite imaging market globally, accounting for a major share of the revenues in 2016. The market for disaster management is expected to grow at the highest pace during the forecast period. On the other hand, commercial enterprise has been the major end-user in commercial satellite imaging market, whereas defence segment is expected to be the fastest growing end-user industry during forecast period.

Geographically, North America has been the largest market for commercial satellite imaging and Asia-Pacific had been the fastest growing regional market. North America is expected to account for over 40% of the global commercial satellite imaging market in 2023. By country, the U.S. stands as the largest market globally, whereas the commercial satellite imaging market in India has been growing at highest pace.

Satellite imaging is widely used for image capturing, which can offer valuable data and information, used by government and research organizations across various sectors for various applications including weather information and forecasting, farming and forestry. In addition, the companies involved in offering commercial satellite imaging products and services are heavily investing in research & development to enhance high-resolution cameras and advance sensing technology, which would further help in improving the quality of satellite-based Earth Observation (EO) images.

The research states that the global commercial satellite imaging market is moderately competitive, with players developing advance Earth imagery and data analytics solutions. Some of the key players operating in the global commercial satellite imaging market are DigitalGlobe, Inc., Galileo Group, Inc., Spaceknow, Inc., Environmental Systems Research Institute, and Airbus Defence and Space.

New Courtesy : P&S Market Research

 

Global Robotic Process Automation Market to Reach $6,247.1 Million by 2023

Due to significant growth in technologies such as artificial intelligence and cognitive learning, adoption of business automation technologies by enterprises has also increased. This has led to rapid increase in demand for virtual workforce to eliminate repetitive human efforts, on the back of which, the global robotic process automation market is gaining traction.

Insights on market segments

As per the findings of the research, rule based operations have been the largest revenue generators in the global robotic process automation market, as compared to knowledge based operations. Further, among various processes, automation solutions segment is expected to continue its highest revenue contribution to the market, during the forecast period. Among various industries, retail and consumer goods witnessed the highest growth in demand of robotic process automation, during 2014 – 2016. However, banking, financial services and insurance (BFSI) is expected to hold the largest market during the forecast period.

The market to witness fastest growth in Asia-Pacific during the forecast period

Geographically, North America has been the largest market for robotic process automation, whereas Asia-Pacific is expected to witness the fastest growth among all regions, during the forecast period. The anticipated growth in the market can be attributed to factors such as advancement in new technologies, growing digitalization, growth in automation software industry, and increasing adoption of business process automation solutions by small and medium scale enterprises in the region.

Rule based operations to lead robotic process automation market globally

Rule based robotic process automation operations has been the largest contributor to the global robotic process automation market. This operation uses sophisticated computer software that automate rule-based processes, which are statements pre-defined in a software system, without the need for constant supervision of human workforce. The rule based operation has gained significant interest from all sized enterprises as it enables organizations to configure software robots that effectively automate various annual and highly repetitive tasks.

Increase in demand for virtual workforce escalates the global market growth

Factors driving the growth of the global robotic process automation market include significant increase in ease of doing business through installation of robotic process automation, surge in demand for virtual workforce to eliminate repetitive human tasks, decreasing cost of automation software and services, and increased adoption of new automation technologies for business transformations. While businesses across the globe need advanced solutions to investigate and solve critical short term business issues, such as changing market trends and consumer preferences, robotic process automation helps them in improving service desk operations and monitoring various business tasks such as production and product development effectively.

Moderate competition among key players

The research states that the global robotic process automation market is moderately competitive, with players developing new robotic process automation applications. Some of the key players operating in the robotic process automation ecosystem are Nice Systems Ltd., Pegasystems Inc., Automation Anywhere, Blue Prism PLC, Ipsoft, Inc., Celaton Ltd., Redwood Software, Uipath SRL, Verint System Inc., Xerox Corporation, and IBM Corporation.

News Courtesy : P&S Market Research